We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA |

Highlights FREE

JAMA. 2015;313(14):1393-1395. doi:10.1001/jama.2014.11679.
Text Size: A A A
Published online


In a retrospective cohort study involving 322 323 children, Xiang and colleagues assessed the relationship between intrauterine exposure to maternal type 2 diabetes (n = 6496) or gestational diabetes (n = 25 035) and the risk of an autism spectrum disorder diagnosis. In analyses adjusted for potential confounders, the authors found that compared with no diabetes exposure, exposure to maternal gestational diabetes diagnosed before 26 weeks’ gestation—but not maternal preexisting type 2 diabetes—was associated with an increased risk of autism spectrum disorders in the offspring.

Among nonelderly patients with mitral valve disease requiring valve replacement, the best prosthesis—bioprosthetic or mechanical—is not clear. In a retrospective cohort study that involved 3433 patients aged 50 to 69 years who were undergoing primary isolated mitral valve replacement, Chikwe and colleagues assessed survival and major morbidity outcomes during 15 years of follow-up. In a propensity score–matched analysis (664 patient pairs), the authors found no survival difference among patients who received a mechanical vs bioprosthetic valve replacement. Mechanical valves were associated with a lower risk of reoperation but greater risk of bleeding and stroke.

Observational data suggest that patient adherence to dabigatran—a target-specific oral anticoagulant—may be suboptimal and associated with increased risk of stroke and death. To explore site-level, practice-related factors possibly associated with dabigatran adherence, Shore and colleagues analyzed data from 4863 patients prescribed dabigatran at 67 Veterans Administration health care sites. The authors found significant variability in patient medication adherence across sites. Factors associated with higher levels of adherence included appropriate patient selection and pharmacist-led adverse event and adherence monitoring.


Prabhakaran and colleagues report results of a systematic review of the evidence supporting reperfusion treatment in acute ischemic stroke (68 articles; 108 082 patients). Among the authors’ findings was that intravenous thrombolysis with recombinant tissue plasminogen activator remains the standard of care for patients with moderate to severe neurologic deficits who present within 4.5 hours of symptom onset. Mechanical thrombectomy has been associated with improved outcomes in select patients.

An article in JAMA Surgery reported widespread adoption of damage control resuscitation policies—early administration of blood products, aggressive correction of coagulopathy, and minimization of crystalloid fluids—in forward combat hospitals since 2006 and described trends in combat-related injury type and severity and in-hospital mortality. This From The JAMA Network article by Holcomb and Hoyt highlights the need for comprehensive civilian trauma research.

Schmidt-Hansen and colleagues summarize a Cochrane review (45 studies; 6095 patients) that addressed the accuracy of fludeoxyglucose F 18-positron emission tomography/computed tomography (FDG-PET/CT) imaging to detect mediastinal lymph node involvement in patients with potentially resectable non–small cell lung cancer (NSCLC). The accuracy of FDG-PET/CT imaging alone is insufficient to make a decision about whether to proceed directly to surgery as a single treatment option.

Altkorn and Cifu summarize the 2014 Clinician’s Guide to the Prevention and Treatment of Osteoporosis developed by the National Osteoporosis Foundation. Recommendations include bone mineral density testing for women aged 65 years or older and men aged 70 years or older. Bone mineral density testing may be considered for younger individuals with risk factors or prior (adult) fracture.



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.